The new Italian law 219/2017: an extraordinary clinical tool in internal medicine

  • Matteo Bolcato Department of Molecular Medicine, Legal Medicine, University of Padua, Padua, Italy.
  • Giacomo Fassina Department of Molecular Medicine, Legal Medicine, University of Padua, Padua, Italy.
  • Matteo Sanavio | matteo.sanavio@studenti.unips.it Department of Molecular Medicine, Legal Medicine, University of Padua, Padua, Italy.
  • Anna Aprile Department of Molecular Medicine, Legal Medicine, University of Padua, Padua, Italy.

Abstract

In December 2017, Law 219 named ‘Provisions for informed consent and advance treatment directives’ was approved in Italy, and on the one hand, this law helped the daily medical activity, and on the other hand, it enhanced the patient’s self-determination. This contribution analyzes the new legislative disposition and the possible medical-legal and practical implications for patients entrusted in hospitals. In particular, it focuses on the usefulness of early planning of medical care decisions in complex pathological situations in order to enhance the patient’s self-determination and his eventual impassable refusal. It also safeguards the medical work from disputes and claims, preserving medical autonomy and competence.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-05-15
Info
Issue
Section
FADOI Position Statement
Keywords:
Informed consent, patients’ self-determination, shared care planning, advance directives.
Statistics
  • Abstract views: 134

  • PDF: 113
  • HTML: 0
How to Cite
Bolcato, M., Fassina, G., Sanavio, M., & Aprile, A. (2020). The new Italian law 219/2017: an extraordinary clinical tool in internal medicine. Italian Journal of Medicine, 14(3), 184-188. https://doi.org/10.4081/itjm.2020.1280